Grant Proposal on Outcomes of Fibrinolytic Therapy Versus PCI
Evidence based medicine requires foundational inquiry and support. Heart disease, thrombolytic disease, pulmonary embolism, deep vein thrombosis, stroke and preliminary stroke occurrences and myocardial infarction are fundamentally significant challenges in medicine and community. Treatment of varied presentations of thrombolytic crisis deserve significant research inquiry and time given the severity of the potential outcomes and the numbers of individuals who seek treatment daily for heart disease and acute cardiac and venous crisis and the number of people who have both positive and negative medical and life outcomes during all levels of intervention. The various treatment options for acute and often potentially deadly cardiac crisis are often well tested and well established, yet they also require constant vigilance on the part of clinical researchers and practitioners to develop appropriate and best practices for best possible outcomes for patients. It is well established that outcomes of fibrinolytic therapy versus primary percutaneous coronary intervention (PCI) vary with the most important functions of PCI being the immediacy of its performance, hence the door-balloon initiative contending that PCI be performed within 90 minutes of entrance for acute ST segment elevation myocardial infarction (STEMI) yet further research must be conducted to reiterate the importance of fibrinolytic therapy in concordance with PCI and also as an alternative when the door-to-balloon window has been bridged over time, be it from time of event beginning or time of treatment exposure.